Literature DB >> 20484671

Fluidizing effects of C-reactive protein on lung surfactant membranes: protective role of surfactant protein A.

Alejandra Sáenz1, Almudena López-Sánchez, Jonás Mojica-Lázaro, Leticia Martínez-Caro, Nicolas Nin, Luís A Bagatolli, Cristina Casals.   

Abstract

The purpose of this study was to investigate how surfactant membranes can be perturbed by C-reactive protein (CRP) and whether surfactant protein A (SP-A) might overcome CRP-induced surfactant membrane alterations. The effect of CRP on surfactant surface adsorption was evaluated in vivo after intratracheal instillation of CRP into rat lungs. Insertion of CRP into surfactant membranes was investigated through monolayer techniques. The effect of CRP on membrane structure was studied through differential scanning calorimetry and fluorescence spectroscopy and microscopy using large and giant unilamellar vesicles. Our results indicate that CRP inserts into surfactant membranes and drastically increases membrane fluidity, resulting in surfactant inactivation. At 10% CRP/phospholipid weight ratio, CRP causes disappearance of liquid-ordered/liquid-disordered phase coexistence distinctive of surfactant membranes. SP-A, the most abundant surfactant lipoprotein structurally similar to C1q, binds to CRP (K(d)=56±8 nM), as determined by solid-phase binding assays and dynamic light scattering. This novel SP-A/CRP interaction reduces CRP insertion and blocks CRP effects on surfactant membranes. In addition, intratracheal coinstillation of SP-A+CRP into rat lungs prevents surfactant inhibition induced by CRP, indicating that SP-A/CRP interactions might be an important factor in vivo in controlling harmful CRP effects in the alveolus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484671     DOI: 10.1096/fj.09-142646

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Folding and Intramembraneous BRICHOS Binding of the Prosurfactant Protein C Transmembrane Segment.

Authors:  Alejandra Sáenz; Jenny Presto; Patricia Lara; Laura Akinyi-Oloo; Belén García-Fojeda; IngMarie Nilsson; Jan Johansson; Cristina Casals
Journal:  J Biol Chem       Date:  2015-06-03       Impact factor: 5.157

2.  Natural Anti-Infective Pulmonary Proteins: In Vivo Cooperative Action of Surfactant Protein SP-A and the Lung Antimicrobial Peptide SP-BN.

Authors:  Juan Manuel Coya; Henry T Akinbi; Alejandra Sáenz; Li Yang; Timothy E Weaver; Cristina Casals
Journal:  J Immunol       Date:  2015-07-10       Impact factor: 5.422

3.  Trace membrane additives affect lipid phases with distinct mechanisms: a modified Ising model.

Authors:  Rebecca L Meerschaert; Christopher V Kelly
Journal:  Eur Biophys J       Date:  2015-03-28       Impact factor: 1.733

4.  Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis.

Authors:  Mario Martínez-Florensa; Cristina Català; María Velasco-de Andrés; Olga Cañadas; Víctor Fraile-Ágreda; Sergi Casadó-Llombart; Noelia Armiger-Borràs; Marta Consuegra-Fernández; Cristina Casals; Francisco Lozano
Journal:  Front Immunol       Date:  2018-04-12       Impact factor: 7.561

5.  Synergistic Action of Antimicrobial Lung Proteins against Klebsiella pneumoniae.

Authors:  Víctor Fraile-Ágreda; Olga Cañadas; Timothy E Weaver; Cristina Casals
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

6.  The collectin SP-A and its trimeric recombinant fragment protect alveolar epithelial cells from the cytotoxic and proinflammatory effects of human cathelicidin in vitro.

Authors:  Lidia de Tapia; Belén García-Fojeda; Nina Kronqvist; Jan Johansson; Cristina Casals
Journal:  Front Immunol       Date:  2022-08-29       Impact factor: 8.786

7.  Cooperative action of SP-A and its trimeric recombinant fragment with polymyxins against Gram-negative respiratory bacteria.

Authors:  Juan Manuel Coya; Víctor Fraile-Ágreda; Lidia de Tapia; Belén García-Fojeda; Alejandra Sáenz; José A Bengoechea; Nina Kronqvist; Jan Johansson; Cristina Casals
Journal:  Front Immunol       Date:  2022-09-07       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.